These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25007911)

  • 1. Challenges and potential barriers to the uptake of antiretroviral-based prevention in Asia and the Pacific region.
    Lo YR; Kato M; Phanuphak N; Fujita M; Duc DB; Sopheap S; Pendse R; Yu D; Wu Z; Chariyalertsak S
    Sex Health; 2014 Jul; 11(2):126-36. PubMed ID: 25007911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The key role of adherence for the effectiveness of antiretroviral-based prevention: state of the science and implications for the Asia-Pacific region.
    Amico KR
    Sex Health; 2014 Jul; 11(2):155-65. PubMed ID: 24331438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challenges.
    Krakower DS; Mayer KH
    Drugs; 2015 Feb; 75(3):243-51. PubMed ID: 25673022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa.
    McGillen JB; Anderson SJ; Hallett TB
    J Int AIDS Soc; 2016; 19(7(Suppl 6)):21104. PubMed ID: 27760682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Antiretroviral Therapy for the Success of Emerging Interventions to Prevent HIV Transmission: A Wake up Call.
    Nachega JB; Uthman OA; Mills EJ; Quinn TC
    J AIDS Clin Res; 2013 Oct; 2012(Suppl 4):. PubMed ID: 24032088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antiretroviral therapy for the prevention of new HIV infection in populations at high risk for HIV sero-conversion in Nigeria.
    Idoko J; Folayan MO
    Afr J Reprod Health; 2014 Sep; 18(3 Spec No):127-34. PubMed ID: 26050385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers and facilitators to pre-exposure prophylaxis (PrEP) eligibility screening and ongoing HIV testing among target populations in Bondo and Rarieda, Kenya: results of a consultation with community stakeholders.
    Mack N; Odhiambo J; Wong CM; Agot K
    BMC Health Serv Res; 2014 May; 14():231. PubMed ID: 24886646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment as Prevention: Concepts and Challenges for Reducing HIV Incidence.
    Brault MA; Spiegelman D; Hargreaves J; Nash D; Vermund SH
    J Acquir Immune Defic Syndr; 2019 Dec; 82 Suppl 2(2):S104-S112. PubMed ID: 31658196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economics, financing and implementation of HIV treatment as prevention: what will it take to get there?
    Wilson D; Taaffe J; Fraser-Hurt N; Gorgens M
    Afr J AIDS Res; 2014; 13(2):109-19. PubMed ID: 25174628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A practical online tool to estimate antiretroviral coverage for HIV infected and susceptible populations needed to reduce local HIV epidemics.
    Chaillon A; Hoenigl M; Mehta SR; Weibel N; Little SJ; Smith DM
    Sci Rep; 2016 Jun; 6():28707. PubMed ID: 27337983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas.
    Holt M
    Sex Health; 2014 Jul; 11(2):166-70. PubMed ID: 23866853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rapid review of pre-exposure prophylaxis for HIV in the Asia-Pacific region: recommendations for scale up and future directions.
    Haldar P; Reza-Paul S; Daniel RA; Lazarus L; Rewari BB; Lorway R; Steen R
    Sex Health; 2021 Mar; 18(1):31-40. PubMed ID: 33632382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review: [corrected] The changing face of the HIV epidemic in sub-Saharan Africa.
    Mutevedzi PC; Newell ML
    Trop Med Int Health; 2014 Sep; 19(9):1015-28. PubMed ID: 24976370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?
    Verguet S; Stalcup M; Walsh JA
    Sex Transm Infect; 2013 Dec; 89(8):628-34. PubMed ID: 23912819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethical use of antiretroviral resources for HIV prevention in resource poor settings.
    Rennie S
    Dev World Bioeth; 2013 Aug; 13(2):79-86. PubMed ID: 23724978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HIV epidemic in Latin America: accomplishments and challenges on treatment and prevention.
    Luz PM; Veloso VG; Grinsztejn B
    Curr Opin HIV AIDS; 2019 Sep; 14(5):366-373. PubMed ID: 31219888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.
    Gomez GB; Borquez A; Caceres CF; Segura ER; Grant RM; Garnett GP; Hallett TB
    PLoS Med; 2012; 9(10):e1001323. PubMed ID: 23055836
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.